Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF605 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | SIK3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RP3-461F17.3 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | ZNF518A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | VHL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | CTD-2331H12.8 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | FBXL17 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | RP5-994D16.11 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | RNF103 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |